Welcome to our dedicated page for Corvex news (Ticker: MOVE), a resource for investors and traders seeking the latest updates and insights on Corvex stock.
Movano Inc. (Nasdaq: MOVE), doing business as Movano Health, generates news at the intersection of wearable medical devices, health technology, and corporate transformation. Founded in 2018, the company develops devices such as the Evie and EvieMED rings, which are designed to bring medical-grade data into consumer and enterprise wearables. Its disclosures highlight capabilities that span physiological monitoring, women’s wellness, and proprietary RF-based sensing for cuffless blood pressure and noninvasive glucose monitoring.
News coverage of Movano frequently includes product and technology updates. The company has announced clinical study results for its wrist-worn cuffless blood pressure prototype, noting accuracy within standards recognized by the FDA for wearable, cuffless blood pressure devices and the ability to collect additional vital signs such as pulse rate, SpO2, respiration rate and ECG waveforms. It has also reported enhancements to the Evie Ring’s companion app, including new personalization and trend-tracking features, integration with Apple Health, expanded workout logging, and the introduction of EvieAI, a virtual wellness assistant built from medical journal data.
Movano’s news flow also reflects regulatory and listing developments. The company has issued multiple press releases regarding Nasdaq notifications related to bid price, periodic filing timeliness, and stockholders’ equity requirements, as well as its responses, such as engaging a new independent auditor, submitting compliance plans, and implementing a one-for-ten reverse stock split to support bid price compliance. Investors following MOVE news can track how these steps affect the company’s continued listing on the Nasdaq Capital Market.
A significant portion of recent headlines centers on strategic and transactional events. Movano’s board initiated a process to explore strategic alternatives, including a sale or merger, to maximize shareholder value. This process led to a definitive Agreement and Plan of Merger with Corvex, Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure. Related announcements describe the planned all-stock combination, ownership structure expectations, concurrent financings, and the intention to rename Movano Inc. as Corvex, Inc. upon closing, with the combined company headquartered in Arlington, Virginia. Movano has also communicated that it may market for sale its current operating assets, including the EvieMED Ring and its mmWave RF technology, prior to completion of the merger.
By monitoring the MOVE news feed, readers can follow updates on Movano’s wearable health products, clinical and regulatory milestones, listing status, financing activities, and the progress of its proposed merger with Corvex. This stream of information helps investors and observers understand both the company’s health technology initiatives and its potential evolution into a public vehicle for AI infrastructure through the planned combination.
Corvex (Nasdaq:MOVE) announced additional details for a special 35.8% stock dividend for holders of record at the close of business on March 30, 2026. The distribution date is April 6, 2026. No action or payment is required by eligible stockholders.
Shares will be credited automatically to brokerage accounts or delivered through DTC. No fractional shares will be issued; any fractional entitlements will be paid in cash. The Stock Dividend is payable under the Amended and Restated Agreement and Plan of Merger dated March 19, 2026.
Corvex (NASDAQ: MOVE) completed an all‑stock merger with Movano and will trade as Corvex, Inc. effective March 23, 2026. The combined company named Jay Crystal and Seth Demsey as Co‑CEOs and Co‑Founders, subject to stockholder approval at a May 2026 meeting.
Corvex and Movano raised $40.2 million before the merger. The company declared a stock dividend of 0.358 share per share, record date March 30, 2026 and distribution April 6, 2026.
Corvex (Nasdaq: MOVE) completed an all-stock merger with Movano and will be renamed Corvex, Inc. effective March 23, 2026. The combined company retains the ticker MOVE. Prior to the merger, Corvex and Movano raised $40.2 million to expand AI infrastructure. The merger agreement also includes a stock dividend of 0.358 share per outstanding Movano share, record date March 30, 2026 and distribution on April 6, 2026. Leadership will be led by Jay Crystal and Seth Demsey as co-CEOs and directors, subject to stockholder approval at the May 2026 meeting.
Corvex (MOVE) launched Corvex Secure Model Weights, a patent-pending solution available early on March 12, 2026, that keeps AI model weights encrypted until they are decrypted inside GPU trusted execution environments. The design uses NVIDIA Confidential Computing, Intel TDX, post-quantum Kyber-768 key exchange, and open-source Confidential Containers for auditable, owner-controlled key custody.
Corvex (NASDAQ:MOVE) announced completion and verification of a production deployment of confidential computing on NVIDIA HGX B200 systems on March 3, 2026. The deployment validates encrypted GPU-to-GPU communications across NVIDIA NVSwitch and NVLink and includes CPU and GPU remote attestation via Intel Trust Authority.
This establishes confidential computing as a production-ready infrastructure primitive for AI workloads, delivering near-native performance while providing runtime cryptographic proof of platform integrity to support regulated, multi-tenant, and sovereign AI deployments.
Corvex (NYSE:MOVE) announced completion and verification of a production deployment of confidential computing on NVIDIA HGX B200 systems on March 3, 2026. The deployment validates encrypted GPU-to-GPU communication across NVIDIA NVSwitch and NVLink using Intel Trust Domain Extensions and NVIDIA Confidential Computing, with CPU and GPU remote attestation via Intel Trust Authority.
This establishes confidential computing as an operational, production-ready infrastructure primitive for AI workloads, claiming near-native performance while protecting data and models in use to support regulated, multi-tenant, and sovereign AI deployments.
Corvex (NYSE:MOVE) announced a long-term lease to deploy a dedicated cluster of NVIDIA H200 GPUs for an AI-driven high-performance battery technologies provider on January 22, 2026. Corvex will supply hyperscaler-class, fully managed GPU infrastructure and a Kubernetes service designed to maximize compute density, reduce idle capacity, and allow burst scaling for peak training and inference workloads. The solution includes a secure on-premise option with hardware-enforced encryption, remote attestation, and payload-free telemetry to support sensitive model training, data-sovereignty, and enterprise compliance.
This deployment aims to enable the customer to expand into security-conscious enterprise markets while lowering infrastructure operating burden and cost relative to public hyperscalers.
Movano (NASDAQ: MOVE) and Corvex announced an all-stock merger effective Nov 10, 2025 that will bring Corvex public via combination into a pure-play AI infrastructure platform.
Key terms: merger exchange ratio tied to a $6.25 per Movano share, Corvex and Movano raised an aggregate $40.0 million in concurrent private placements, and Corvex shareholders will receive 46.6 million shares of Movano.
Movano Health will resume marketing its medical device operations including the FDA-cleared EvieMED Ring and proprietary mmWave RF technology.
Movano Health (NASDAQ: MOVE) will implement a 1-for-10 reverse stock split effective 12:01 a.m. Eastern on October 10, 2025. Shares are expected to trade on a split-adjusted basis when markets open on October 10, 2025, and the company will continue to trade under the symbol MOVE. The new CUSIP will be 62459M305. Outstanding shares will be reduced from approximately 8.3 million to approximately 0.8 million. The Reverse Stock Split is intended to increase the bid price to regain compliance with Nasdaq minimum bid price rules. Fractional shares will be paid in cash; equity awards will receive proportionate adjustments.
Movano Health (Nasdaq: MOVE) has received a listing extension from the Nasdaq Hearings Panel to maintain its listing status. The company must meet two key conditions: file its Q1 and Q2 2025 quarterly reports by September 30, 2025, and demonstrate compliance with the $1.00 minimum bid price requirement by October 30, 2025.
To address the bid price requirement, Movano has scheduled a shareholder meeting for September 26, 2025, where stockholders will vote on a proposed reverse stock split. The company is actively working with its new auditor to complete and file the delayed quarterly reports within the extension period.